MedTrace Logo

Topical Hydromorphone for Wound Healing

NCT00177060 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-03-01

No results posted yet for this study

Summary

The hypothesis is that topical opioids will hasten wound healing in humans.

Conditions

  • Wound Healing

Interventions

DRUG

hydromorphone

Sponsors & Collaborators

  • Hordinsky, Maria K., MD

    lead INDIV

Principal Investigators

  • Maria Hordinsky, MD · University of Minnesota

  • Robert Hebbel, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-10-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177060 on ClinicalTrials.gov